Evidence map›Paper›PMID 40687783›Full record

ArticleiScience2025

Predicting

Hui Cheng, Jing Ding, Juan Wang, Yujun Xiao, Xinyi Jin, Yan Zhang, Yuanyuan Yang, Huangmeng Xu, Xinyi Cao, Fangyu Guo and 3 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hui ChengDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Jing DingDepartment of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Juan WangDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yujun XiaoDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Xinyi JinDepartment of Medical Development, Hangzhou Zhiwei Information and Technology Co., Ltd., Hangzhou, China.
Yan ZhangDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Yuanyuan YangDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Huangmeng XuDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Xinyi CaoDepartment of Medical Development, Hangzhou Zhiwei Information and Technology Co., Ltd., Hangzhou, China.
Fangyu GuoDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Jianmin YangDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Jiatao LouDepartment of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gusheng TangDepartment of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of the

Indexed as

Artificial intelligenceDiagnosticsOncology

Identifiers

PMID40687783
PMCPMC12274885

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.